Endothelial function in proteinuric renal disease

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Joles, Jaap A ^a   Stroes, Erik S G ^a   Rabelink, Ton J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Nephrology and Hypertension ^*  (Netherlands)

Author keywords

Albumin; Cardiovascular; Dyslipidemia; Lipids; Nitric oxide

Indexed keywords

ALBUMIN; ARGININE; CAVEOLIN; CHOLESTEROL; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C;

BLOOD PRESSURE; CARDIOVASCULAR RISK; CELL MEMBRANE; CONFERENCE PAPER; DYSLIPIDEMIA; ENDOTHELIUM; ENZYME BINDING; ERYTHROCYTE DEFORMABILITY; HEART INFARCTION; HYPERCHOLESTEROLEMIA; HYPOALBUMINEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VASOCONSTRICTION; ANIMAL; HUMAN; KIDNEY DISEASE; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY DISEASES; PROTEINURIA;

EID: 0033050485     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BROWN JH, HUNT LP, VITES NP, SHORT CD, GOKAL R, MALLICK NP: Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 9:1136-1142, 1994
2. WEVER RMF, LUSCHER TF, COSENTINO F, RABELINK TJ: Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97:108-112, 1997
3. SASE K, MICHEL T: Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med 7:28-37, 1997
4. WEVER RMF, VAN DAM T, VAN RUN HJM, DE GROOT F, RABELINK TJ: Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 237:340-344, 1997
5. STROES E, HIJMERING M, VAN ZANDVOORT M, WEVER R, RABELINK TJ, VAN FAASSEN EE: Origin of superoxide production by endothelial nitric oxide synthase. FEBS letters 438:161-164, 1998
6. STROES ES, KOOMANS HA, DE BRUIN TW, RABELINK TJ: Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346:467-471, 1995
7. STROES ESG, DE BRUIN TWA, VALK HW, ERKELENS DW, BANGA JD, VAN RUN HJ, KOOMANS HA, RABELINK TJ: NO-activity in familial combined hyperlipidemia; potential role of cholesterol remnants. Cardiovasc Res 36:445-452, 1997
8. WEVER R, BOER P, STROES ESG, HIJMERING M, VERHAAR M, KOOMANS HA, RABELINK TJ: Different mechanisms of endothelial dysfunction between hypercholesterolemia and renal failure. After Thromb Vasc Biol (in press)
9. DULAK J, POLUS M, GUEVARA I, HARTWICH J, DEMBINSKA-KIEC A: Regulation of inducible nitric oxide synthase and GTP cyclohydrolase I gene expression by ox-LDL in rat vascular smooth muscle cells. J Physiol Pharmacol 4:689-697, 1997
10. STROES ESG, KASTELEIN JJ, COSENTINO F, ERKELENS DW, WEVER R, KOOMANS HA, LUSCHER TF, RABELINK TJ: Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99:41-46, 1997
11. BOGER RH, BODE-BOGER SM, BRANDES RP, PHIVTONG-NGAM L, BOHME M, NAFE R, MUGGE A, FROHLICH JC: Dietary L-arginine reduces the progression of atherosclerosis in cholesterol fed rabbits: Comparison with lovastatin. Circulation 96:1282-1290, 1997
12. NISHIMURA JS, MARTASEK P, MCMILLAN K, SALERNO JC, LIU Q, GROSS SS, MASTERS BSS: Modular structure of neuronal nitric oxide synthase: Localization of the arginine binding site and modulation by pterin. Biochem Biophys Res Commun 210:288-294, 1995
13. ORDONNEZ JD, HIATT RA, KILLEBREW EJ, FIREMAN BH: The increased risk of coronary heart disease associated with the nephrotic syndrome. Kidney Int 44:638-642, 1992
14. STROES ESG, JOLES JA, CHANG PC, KOOMANS HA, RABELINK TJ: Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 48:544-550, 1995
15. SAIN-VAN DER VELDEN MGM, KAYSEN GA, BARRETT HA, STELLAARD F, GADELLAA MM, VOORBIJ HAN, REIJNGOUD D-J, RABELINK TJ: Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int 53:994-1001, 1998
16. 2 activity in endothelial cell-induced modifications of low-density lipoprotein. Proc Natl Acad Sci USA 82:3000-3004, 1985
17. KUGIYAMA K, KERNS SA, MORRISETT JD, ROBERTS R, HENRY PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-162, 1990
18. OHGUSHI M, KUGIYAMA K, FUKUNAGA K, MUROHARA T, SUGIYAMA S, MIYAMOTO E, YASUE H: Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler Thromb 13:1525-1532, 1993
19. SWITZER S, EDER HA: Transport of lysolecithin by albumin in human and rat plasma. J Lipid Res 6:506-511, 1965
20. JOLES JA, WILLEKES-KOOLSCHIJN N, SCHEEK LM, KOOMANS HA, RABELINK TJ, VAN TOL A: Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats. Kidney Int 46:97-104, 1994
21. VUONG TD, STROES ESG, WILLEKES-KOOLSCHIJN N, RABELINK TJ, KOOMANS HA, JOLES JA: Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects. Kidney Int 55:1005-1010, 1999
22. ZWAGINGA JJ, KOOMANS HA, SIXMA JJ, RABELINK TJ: Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest 93:204-211, 1994
23. JOLES JA, WILLEKES-KOOLSCHIJN N, KOOMANS HA: Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int 52:761-770, 1997
24. STOLL LL, OSKARSSON HJ, SPECTOR AA: Interaction of lysophosphatidylcholine with aortic endothelial cells. Am J Physiol 262: H1853-H1860, 1992
25. FREEMAN JE, KUO WY, DRENGER B, BARNETT TN, LEVINE MA, FLAVAHAN NA: Analysis of lysophophatidylcholine induced endothelial dysfunction. J Cardiovasc Pharmacol 28:345-352, 1996
26. OISHI K, RAYNOR RL, CHARP PA, KUO JF: Regulation of protein kinase C by lysophospholipids: Potential role in signal transduction. J Biol Chem 263:6865-6871, 1988
27. ITO M, NARUSE A, YAMAMOTO I, OGURI M, SUZUKI Y, SATAKE N, SHIBATA S: Nephrosis augments contractile response to adrenocep-tor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells. J Pharmacol Exp Ther 269:589-595, 1994
28. FUIANO G, ESPOSITO C, SEPE V, COLUCCI G, BOVINO M, ROSA M, BALLETTA M, BELLINGHIERI G, CONTE G, CIANCIARUSO B, CANTON AD: Effects of hypercholesterolemia on renal hemodynamics: study in patients with nephrotic syndrome. Nephron 73:430-435, 1996